Cart
sales@molnova.com
N-Desmethyl imatinib
CAS No. 404844-02-6
N-Desmethyl imatinib( Norimatinib | Imatinib metabolite N-Desmethyl imatinib )
Catalog No. M26257 CAS No. 404844-02-6
N-Desmethyl imatinib is a metabolite of Imatinib, which is a multi-target inhibitor of c-Kit, v-Abl, and PDGFR.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 160 | In Stock |
|
| 10MG | 302 | In Stock |
|
| 25MG | 512 | In Stock |
|
| 50MG | 736 | In Stock |
|
| 100MG | 1017 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameN-Desmethyl imatinib
-
NoteResearch use only, not for human use.
-
Brief DescriptionN-Desmethyl imatinib is a metabolite of Imatinib, which is a multi-target inhibitor of c-Kit, v-Abl, and PDGFR.
-
DescriptionN-Desmethyl imatinib is a metabolite of Imatinib, which is a multi-target inhibitor of c-Kit, v-Abl, and PDGFR.
-
In Vitro——
-
In Vivo——
-
SynonymsNorimatinib | Imatinib metabolite N-Desmethyl imatinib
-
PathwayAngiogenesis
-
TargetBcr-Abl
-
RecptorBacterial
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number404844-02-6
-
Formula Weight479.588
-
Molecular FormulaC28H29N7O
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (208.52 mM)
-
SMILESCc1ccc(NC(=O)c2ccc(CN3CCNCC3)cc2)cc1Nc1nccc(n1)-c1cccnc1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Kim B, et al. Differential effects of alkyl gallates on quorum sensing in Pseudomonas aeruginosa. Sci Rep. 2019;9(1):7741. Published 2019 May 23.
molnova catalog
related products
-
Gypsogenin
Gypsogenin is a naturally occurring biochemical that shows anti-ABL1 kinase and anti-chronic Myelogenous Leukemia activities.
-
CHMFL-ABL-039
CHMFL-ABL-039 is a type II native ABL kinase and drug-resistant V299L mutant BCR-ABL inhibitor (IC50s: 7.9 nM and 27.9 nM) used in the research of chronic myeloid leukemia.
-
Asciminib
Asciminib (ABL-001) is a potent and selective allosteric ABL1 inhibitor with IC50 of 0.25 nM in BCR–ABL1-transformed BaF3 cells.
